Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente JOURNAL OF HEPATOLOGY

Tipo Año Título Fuente
Revisión2024Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directionsJOURNAL OF HEPATOLOGY
Artículo2024Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.JOURNAL OF HEPATOLOGY
Artículo2024Predicting survival in patients with ‘non-high-risk’ acute variceal bleeding receiving β-blockers+ligation to prevent re-bleedingJOURNAL OF HEPATOLOGY
Artículo2023A global research priority agenda to advance public health responses to fatty liver diseaseJOURNAL OF HEPATOLOGY
Revisión2023A multisociety Delphi consensus statement on new fatty liver disease nomenclatureJOURNAL OF HEPATOLOGY
Artículo2023A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver diseaseJOURNAL OF HEPATOLOGY
Artículo2023Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosisJOURNAL OF HEPATOLOGY
Artículo2023An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography.JOURNAL OF HEPATOLOGY
Resumen congreso2023Analysis of the diagnostic accuracy of the non-invasive fibrosis indices NFS, HFS, and FIB-4 in the staging of advanced fibrosis in patients with metabolic fatty liver: meta-analysis of comparative studiesJOURNAL OF HEPATOLOGY
Resumen congreso2023Biomarkers of endothelial dysfunction in patients with nonalcoholic fatty liver disease (NAFLD)JOURNAL OF HEPATOLOGY
Corrección2023Corrigendum to “Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis” (Journal of Hepatology (2023) 79(4) (967–976), (S0168827823003513), (10.1016/j.jhep.2023.05.022))JOURNAL OF HEPATOLOGY
Corrección2023Corrigendum to “EASL clinical practice guidelines on the management of hepatic encephalopathy” [J Hepatol 2022 (77) 807–824](S0168827822003464)(10.1016/j.jhep.2022.06.001)JOURNAL OF HEPATOLOGY
Artículo2023Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosisJOURNAL OF HEPATOLOGY
Resumen congreso2023Development and validation of the AMMON-OHE model to risk stratify cirrhotic outpatients for ocurrence of overt hepatic encephalopathyJOURNAL OF HEPATOLOGY
Resumen congreso2023Diagnostic accuracy of magnetic resonance elastography, transient elastographyand predictive scores in cystic fibrosis related liver steatosis and fibrosisJOURNAL OF HEPATOLOGY
Resumen congreso2023Endothelial and platelet-derived microvesicles as a biomarker of cardiovascular risk in patients with metabolic dysfunction-associated fatty liver disease (MAFLD)JOURNAL OF HEPATOLOGY
Resumen congreso2023First nationwide genetic study on Wilson disease (Spanish Wilson registry): high diversity in mutations and in use of genetic evaluation, association with clinical data and influence on diagnosis and health costsJOURNAL OF HEPATOLOGY
Resumen congreso2023Histological and biopsychosocial predictors of quality of life in Spanish and UK cohorts of patients with non-alcoholic fatty liver diseaseJOURNAL OF HEPATOLOGY
Resumen congreso2023Histological classifications versus liver-related events: results from the multicentric, European, hepatic outcomes and survival fatty liver registry (HOTSURFR) studyJOURNAL OF HEPATOLOGY
Resumen congreso2023Impact of obesity on transient elastography accuracy among patients with non-alcoholic fatty liver diseaseJOURNAL OF HEPATOLOGY
Resumen congreso2023Impact of the metabolic profile on the response to ursodeoxycholic acid in patients with primary biliary cholangitis: results of the ColHai registryJOURNAL OF HEPATOLOGY
Resumen congreso2023Lessons from population genomics for Wilson disease: Prevalence, penetrance of mutations, clinical implications and design of regional screening programmesJOURNAL OF HEPATOLOGY
Resumen congreso2023Long-term prospective follow-up of a primary biliary cholangitis (PBC) multicenter cohort treated with Obeticholic Acid (OCA). Interaction effect of triple therapy with fibratesJOURNAL OF HEPATOLOGY
Resumen congreso2023Main clinical characteristics and evolutionary events among patients suffering Wilson disease in Spain: first results from the Spanish Wilson registryJOURNAL OF HEPATOLOGY
Resumen congreso2023Novel artificial intelligence-assisted digital pathology quantitative image analysis predicts the occurrence of liver-related clinical events in the multicentric, European, hepatic outcomes and survival fatty liver registry (HOTSURFR) studyJOURNAL OF HEPATOLOGY
Resumen congreso2023Risk of decompensated cirrhosis in patients with primary biliary cholangitis under first, second and third-line therapiesJOURNAL OF HEPATOLOGY
Resumen congreso2023Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebocontrolled trialJOURNAL OF HEPATOLOGY
Resumen congreso2023Significant fibrosis is a risk factor for worse health perception and impaired mental health in people living with HIVJOURNAL OF HEPATOLOGY
Resumen congreso2023Single-cell RNA sequencing in DIAMOND mice reveals differentially regulated pathways specifically associated with the transition from simple steatosis towards NASHJOURNAL OF HEPATOLOGY
Resumen congreso2023The combination of LACE index, MELDon discharge and a previous history of decompensation defines risk groups for early readmission in patients with liver cirrhosisJOURNAL OF HEPATOLOGY
Resumen congreso2023Variation in the presentation pattern of primary biliary cholangitis (PBC) in Spain according to the diagnostic period: data from the Spanish registry of cholestatic and autoimmune liver diseases (COLHAI)JOURNAL OF HEPATOLOGY
Resumen congreso2022Approaches for a hepatitis C-free city: preliminary resultsJOURNAL OF HEPATOLOGY
Resumen congreso2022Confounding factors in diagnostic performance of magnetic resonance elastography for staging liver fibrosis in patients with non-alcoholic fatty liver disease: an individual patient data meta-analysisJOURNAL OF HEPATOLOGY
Resumen congreso2022Cumulative exposure to tacrolimus and incidence of cancer after liver transplantationJOURNAL OF HEPATOLOGY
Resumen congreso2022Diagnostic accuracy of MRE for staging hepatic fibrosis in patients with NAFLDJOURNAL OF HEPATOLOGY
Resumen congreso2022Dysregulation of the urea cycle enzymes determines a more severe NAFLD phenotype in a DIAMOND preclinical modelJOURNAL OF HEPATOLOGY
Artículo2022EASL Clinical Practice Guidelines on the management of hepatic encephalopathyJOURNAL OF HEPATOLOGY
Resumen congreso2022Identification of new potential biomarkers to follow steatohepatitis in patients with non-alcoholic/metabolic-associated fatty liver diseaseJOURNAL OF HEPATOLOGY
Artículo2022Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial functionJOURNAL OF HEPATOLOGY
Resumen congreso2022MAP17 promotes metastasis in hepatocellular carcinoma by modulating the epithelial-mesenchymal-amoeboid transitionJOURNAL OF HEPATOLOGY
Artículo2022Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related eventsJOURNAL OF HEPATOLOGY
Artículo2022Orthohepevirus C infection as an emerging cause of acute hepatitis in Spain: first report in EuropeJOURNAL OF HEPATOLOGY
Artículo2022Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosisJOURNAL OF HEPATOLOGY
Resumen congreso2022Safety and effectiveness of vaccines agains SARS-COV-2 in patients with liver cancer. VacHep registry: response analysis 4 weeks after the second dose.JOURNAL OF HEPATOLOGY
Resumen congreso2022Targeting cyclin M4 as a new therapeutical approach to treat alcoholic liver diseaseJOURNAL OF HEPATOLOGY
Artículo2022The global NAFLD policy review and preparedness index: are countries ready to address this silent public health challenge?JOURNAL OF HEPATOLOGY
Artículo2021Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis.JOURNAL OF HEPATOLOGY
Artículo2021Coexpression gene network analysis reveals novel regulatory pathways involved in porto-sinusoidal vascular disease.JOURNAL OF HEPATOLOGY
Artículo2021Comprehensive analysis and insights gained from long-term experience of the Spanish DILI RegistryJOURNAL OF HEPATOLOGY
Artículo2021Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysisJOURNAL OF HEPATOLOGY
Editorial2021EASL international recognition award recipient 2021: Prof. Dr. Nahum Méndez-SánchezJOURNAL OF HEPATOLOGY
Artículo2021Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patientsJOURNAL OF HEPATOLOGY
Resumen congreso2021Impact of a loss-of-function variant in HSD17B13 on hepatic decompensation and mortality in cirrhotic patientsJOURNAL OF HEPATOLOGY
Artículo2021Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease.JOURNAL OF HEPATOLOGY
Artículo2021PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosisJOURNAL OF HEPATOLOGY
Resumen congreso2021Relevance of psychosocial biomarkers on therapeutic adherence in patients with non-alcoholic fatty liver diseaseJOURNAL OF HEPATOLOGY
Letter2021Reply to: “The predictive value of significant fibrosis for metabolic disturbances in patients with NAFLD”JOURNAL OF HEPATOLOGY
Artículo2020A cross-sectional study of the public health response to non-alcoholic fatty liver disease in EuropeJOURNAL OF HEPATOLOGY
Revisión2020A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementJOURNAL OF HEPATOLOGY
Resumen congreso2020Circulating PCSK9 levels correlated with advanced disease in patients with biopsy-proven non-alcoholic fatty liver diseaseJOURNAL OF HEPATOLOGY
Corrección2020Erratum to: “Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH JOURNAL OF HEPATOLOGY
Resumen congreso2020Identification of novel biomarkers and therapeutic targets for steatohepatitis and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD): an in silico analysisJOURNAL OF HEPATOLOGY
Resumen congreso2020Liver derived apoptotic microparticles as biomarkers to detect transition from simple steatosis to steatohepatitis in non-alcoholic fatty liver diseaseJOURNAL OF HEPATOLOGY
Resumen congreso2020LncRNA-H19 as a marker of liver progression from steatosis to hepatocellular carcinomaJOURNAL OF HEPATOLOGY
Artículo2020Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPSJOURNAL OF HEPATOLOGY
Resumen congreso2020Relevance of social support and severity of liver disease in biopsychosocial profiles of patients with non-alcoholic fatty liver diseaseJOURNAL OF HEPATOLOGY
Artículo2020Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trialsJOURNAL OF HEPATOLOGY
Artículo2020Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASHJOURNAL OF HEPATOLOGY
Artículo2020The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiologyJOURNAL OF HEPATOLOGY
Artículo2019A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3 ' UTRJOURNAL OF HEPATOLOGY
Letter2019Cross-country migration linked to people who inject drugs challenges the long-term impact of national HCV elimination programmesJOURNAL OF HEPATOLOGY
Resumen congreso2019Effects of fatty acids and polyphenols from extra virgin olive oil in a murine animal dietary model knockout for the LDL receptorJOURNAL OF HEPATOLOGY
Resumen congreso2019Effects of sustained virological response on the endothelial dysfunction and the cardiovascular risk in hepatitis C after direct antiviral angets treatment: HEPCAR studyJOURNAL OF HEPATOLOGY
Resumen congreso2019Epigenetic regulation of gene expression in a HCC-NASH murine modelJOURNAL OF HEPATOLOGY
Resumen congreso2019Factors predicting survival in patients with high-risk acute variceal bleeding treated with pre-emptive (Early)-TIPSJOURNAL OF HEPATOLOGY
Editorial2019Hepatic encephalopathy and traffic accidents: Vigilance is needed!JOURNAL OF HEPATOLOGY
Artículo2019High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real worldJOURNAL OF HEPATOLOGY
Resumen congreso2019Impact of age on routinely available non-invasive tests for the discrimination of advanced fibrosis due to NASH in the phase 3 STELLAR trials of the ASK1 inhibitor selonsertibJOURNAL OF HEPATOLOGY
Artículo2019Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantationJOURNAL OF HEPATOLOGY
Resumen congreso2019Optimal timing of endoscopy is associated with lower 42-day mortality in variceal bleedingJOURNAL OF HEPATOLOGY
Resumen congreso2019Overlap of primary biliary cholangitis and autoimmune hepatitis. Natural history and prognosis in a large cohort of patients from SpainJOURNAL OF HEPATOLOGY
Resumen congreso2019Oxidized LDL is a distinctive biomarker of NASH independently of liver fibrosis in patients with NAFLDJOURNAL OF HEPATOLOGY
Letter2019Reply to: "Cross-country migration linked to people who inject drugs challenges the long-term impact of national HCV elimination programmes''JOURNAL OF HEPATOLOGY
Letter2019Reply to: “Normothermic regional perfusion – What is the benefit?”JOURNAL OF HEPATOLOGY
Resumen congreso2019Respiratory infection in patients with cirrhosis and acute variceal bleeding on antibiotic prophylaxis: A multicenter observational study of 2138 patientsJOURNAL OF HEPATOLOGY
Artículo2019Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapyJOURNAL OF HEPATOLOGY
Resumen congreso2019Rising economic burden following the diagnosis of compensated cirrhosis among hospitalized patients with Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis in SpainJOURNAL OF HEPATOLOGY
Artículo2019Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysisJOURNAL OF HEPATOLOGY
Resumen congreso2019Sumoylation/acetylation drives forward oncogenic role of LKB1 in LiverJOURNAL OF HEPATOLOGY
Resumen congreso2019The combination of HEPAmet fibrosis score and transient elastography shows a high diagnostic accuracy in predicting advanced fibrosis in NAFLDJOURNAL OF HEPATOLOGY
Resumen congreso2019The presence of type 2 diabetes is independently associated with impairment of patient- reported outcomes in patients with non-alcoholic steatohepatitisJOURNAL OF HEPATOLOGY
Resumen congreso2019The socio-economic burden of NASH in Europe and the United States: The gain studyJOURNAL OF HEPATOLOGY
Letter2019The UK DCD Risk Score: Still no consensus on futility in DCD liver transplantationJOURNAL OF HEPATOLOGY
Resumen congreso2019Transcriptomic and epigenetic characterization of a NAFLD murine modelJOURNAL OF HEPATOLOGY
Resumen congreso2019What are the predictors of impairment of patient-reported outcome in non-alcoholic steatohepatitis?JOURNAL OF HEPATOLOGY
Resumen congreso2018Clinical Outcomes in biopsy-proven NAFLD patients from the HEPAmet Spanish RegistryJOURNAL OF HEPATOLOGY
Ponencia2018Continuous infusion of beta-lactam antibiotics in cirrhotic patients with bloodstream infection: results from a prospective multicentre observational studyJOURNAL OF HEPATOLOGY
Resumen congreso2018Critical flicker frequency improves its diagnostic and predictive accuracy of hepatic encephalopathy by decreasing the dispersion between measuresJOURNAL OF HEPATOLOGY
Resumen congreso2018DRESS cases included in the Spanish and Latin-American DILI registries: clinical phenotype and outcomeJOURNAL OF HEPATOLOGY
Resumen congreso2018Effect of hepatitis C sustained virological response on the endothelial dysfunction and the cardiovascular risk. HepCAR studyJOURNAL OF HEPATOLOGY
Resumen congreso2018Genetic and functional analysis of FGF21 in NAFLD/NASHJOURNAL OF HEPATOLOGY
Resumen congreso2018Genetic factors of hepatic encephalopathy on patients with cirrhosis: candidate gene studyJOURNAL OF HEPATOLOGY
Resumen congreso2018Hepamet Score: a new non-invasive method for NAFLD-related fibrosis screening in clinical practiceJOURNAL OF HEPATOLOGY
Artículo2018Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis CJOURNAL OF HEPATOLOGY
Resumen congreso2018Metabolically unhealthy status impacts on the risk of significant liver injury in biopsy-proven NAFLD patients beyond obesityJOURNAL OF HEPATOLOGY
Revisión2018miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysisJOURNAL OF HEPATOLOGY
Artículo2018Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030JOURNAL OF HEPATOLOGY
Resumen congreso2018Molecular characterization of autophagic and apoptotic signaling induced by Sorafenib in liver cancer cells: In vitro and in vivo studiesJOURNAL OF HEPATOLOGY
Resumen congreso2018Pregnancy and autoimmune hepatitis: presentation and outcomesJOURNAL OF HEPATOLOGY
Resumen congreso2018Primary biliary cholangitis in Spain: fewer symptoms and milder disease at presentation, but similar therapeutic response over the yearsJOURNAL OF HEPATOLOGY
Resumen congreso2017A pragmatic algorithm to rule out Non-alcoholic steatohepatitis in patients at risk of non-alcoholic fatty liver disease in spite of a normal ultrasoundJOURNAL OF HEPATOLOGY
Resumen congreso2017Clinical characteristics and outcomes of elderly included in the Spanish Drug-Induced Liver Injury (DILI) RegistryJOURNAL OF HEPATOLOGY
Resumen congreso2017Comprehensive NAFLD diagnosis based on a noninvasive metabolomic approach in a liquid biopsyJOURNAL OF HEPATOLOGY
Editorial2017Detecting liver fat from viscoelasticity: How good is CAP in clinical practice? The need for universal cut-offsJOURNAL OF HEPATOLOGY
Artículo2017Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohortJOURNAL OF HEPATOLOGY
Resumen congreso2017Genetic determinants influencing on overt hepatic encephalopathy and acute-on-chronic liver failureJOURNAL OF HEPATOLOGY
Resumen congreso2017HepCom: impact of co-morbidities on the final success of direct antiviral agents therapy in hepatitis CJOURNAL OF HEPATOLOGY
Resumen congreso2017High efficacy and tolerability of hepatitis C genotype 2 treatment with direct-acting antivirals in real world: analysis of the Hepa-C RegistryJOURNAL OF HEPATOLOGY
Resumen congreso2017Involvement of TA and Delta N p63 and p73 isoforms on the regulation of cell death and tumour recurrence in patients with hepatocarcinoma submitted to liver transplantationJOURNAL OF HEPATOLOGY
Resumen congreso2017Metabolic and biochemical phenotypes can distinguish different patterns of histological severity in biopsy-proven NAFLDJOURNAL OF HEPATOLOGY
Resumen congreso2017Oral glutamine challenge predicts risk and defines hepatic encephalopathy typesJOURNAL OF HEPATOLOGY
Resumen congreso2017Short-term effect of DAA IFN-free regimens on liver stiffnessJOURNAL OF HEPATOLOGY
Resumen congreso2017The hepatoprotective cytokine Cardiotrophin-1 (CT-1) attenuates inflammation and prevents the systemic effects of endotoxemia by promoting M2 macrophage polarizationJOURNAL OF HEPATOLOGY
Resumen congreso2017Time in HE in cirrhotic patients with an acute episode (>= grade 2) determines short and long-term survivalJOURNAL OF HEPATOLOGY
Revisión2017Treatment of NAFLD with diet, physical activity and exerciseJOURNAL OF HEPATOLOGY
Resumen congreso2016A NON-INVASIVE LIPIDOMIC TEST ACCURATELY DISCRIMINATES NON-ALCOHOLIC STEATOHEPATITIS FROM STEATOSIS: A BLIND VALIDATION STUDYJOURNAL OF HEPATOLOGY
Resumen congreso2016A POST-HOC ANALYSIS OF THE GOLDEN505 TRIAL DEMONSTRATES HISTOLOGICAL AND CARDIOMETABOLIC EFFICACY OF ELAFIBRANOR-120 MG IN PATIENTS WITH MODERATE OR SEVERE NASH THAT ARE ELIGIBLE FOR PHARMACOTHERAPYJOURNAL OF HEPATOLOGY
Artículo2016Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injuryJOURNAL OF HEPATOLOGY
Resumen congreso2016DEVELOPMENTAND VALIDATION OF A NON-INVASIVE MODEL FOR PREDICTING FIBROSIS RESOLUTION ONE YEAR AFTER LIFESTYLE INTERVENTION FOR BIOPSY-PROVEN NON-ALCOHOLIC STEATOHEPATITISJOURNAL OF HEPATOLOGY
Artículo2016FibroGENE: A gene-based model for staging liver fibrosisJOURNAL OF HEPATOLOGY
Revisión2016HCV epidemiology in high-risk groups and the risk of reinfectionJOURNAL OF HEPATOLOGY
Resumen congreso2016HCV GENOTYPE 3: META-ANALYSIS WITH AVAILABLE TREATMENT OPTIONSJOURNAL OF HEPATOLOGY
Resumen congreso2016HEPATOTOXICITY ASSOCIATED WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS. A COMPARATIVE ANALYSIS AMONG IBUPROFEN, DICLOFENAC AND NIMESULIDE FROM THE SPANISH AND LATIN-AMERICAN DILI REGISTRIESJOURNAL OF HEPATOLOGY
Resumen congreso2016HIGH RESOLUTION ANALYSIS FOR GENOTYPES AND SUB-GENOTYPES IDENTIFICATION IN HEPATITIS C REVEALS THE IMPORTANCE OF MIXED INFECTIONS FOR OPTIMAL THERAPYJOURNAL OF HEPATOLOGY
Resumen congreso2016IMPACT OF BASAL COMORBIDITIES ON THE OVERALL BENEFIT OF DAA THERAPY IN HEPATITIS CJOURNAL OF HEPATOLOGY
Resumen congreso2016IMPACT OF GWAS-IDENTIFIED COMMON VARIANTS ON HISTOPATHOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTSJOURNAL OF HEPATOLOGY
Resumen congreso2016PLPNA3 STATUS IN NASH IS ASSOCIATED WITH INCREASED HISTOLOGICAL SEVERITY AT BASELINE BUT NOT WITH RESPONSE TO THERAPY IN THE GOLDEN-505 ELAFIBRANOR TRIALJOURNAL OF HEPATOLOGY
Resumen congreso2016RELATIONSHIP BETWEEN BASELINE HEPATIC DISEASE SEVERITY AND THE CARDIOMETABOLIC AND ANTI-INFLAMMATORY EFFECTS OF ELAFIBRANOR IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITISJOURNAL OF HEPATOLOGY
Resumen congreso2016THE FTO RS1421085 T > C POLYMORPHISM IS ASSOCIATED WITH THE SEVERITY OF NON-ALCOHOLIC FATTY LIVERJOURNAL OF HEPATOLOGY
Resumen congreso2016TREATMENT OF HEPATITIS C VIRUS IN PATIENTS WITH ADVANCED CIRRHOSIS: ALWAYS JUSTIFIED? ANALYSIS OF THE HEPA-C REGISTRYJOURNAL OF HEPATOLOGY
Resumen congreso2015CONTINUUM OF CARE OF HEPATITIS C FROM DETECTION TO CURE: IMPACT OF PEER-TO-PEER SESSIONS IN PRIMARY CAREJOURNAL OF HEPATOLOGY
Resumen congreso2015CRITICAL FLICKER FREQUENCY PREDICTS SURVIVAL IN PATIENTS WITH LIVER CIRRHOSISJOURNAL OF HEPATOLOGY
Resumen congreso2015DEVELOPMENT AND VALIDATION OF A SIMPLE CLINICAL PREDICTION MODEL TO IDENTIFY PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS RESOLUTION AFTER 52 WEEKS OF LIFESTYLE MODIFICATIONJOURNAL OF HEPATOLOGY
Resumen congreso2015FIRST REAL CLINICAL PRACTICE DATA ON SOFOSBUVIR, SIMEPREVIR AND DACLATASVIR WITH HCV-CHRONICALLY INFECTED PATIENTS IN SPAIN: THE HepatiC REGISTRY EXPERIENCEJOURNAL OF HEPATOLOGY
Revisión2015Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failureJOURNAL OF HEPATOLOGY
Artículo2015Hepatitis C virus-mediated Aurora B kinase inhibition modulates inflammatory pathway and viral infectivityJOURNAL OF HEPATOLOGY
Resumen congreso2015IMPACT OF PHYSICAL ACTIVITY ON OXIDATIVE STRESS IN PATIENTS WITH HEPATITIS CJOURNAL OF HEPATOLOGY
Resumen congreso2015INFLUENCE OF METABOLIC RISK FACTORS IN HEPATOTOXICITY (DILI) PHENOTYPE AND OUTCOMEJOURNAL OF HEPATOLOGY
Resumen congreso2015METFORMIN REDUCES HYPERAMMONEMIA IN PORTACAVAL SHUNTED RATS INHIBITING GLUTAMINASE ACTIVITYJOURNAL OF HEPATOLOGY
Resumen congreso2015OLIVE OIL COMSUMPTION AMELIORATES NON-ALCOHOLIC STEATOHEPATITIS INDUCED BY HYPERCALORIC AND HYPERLIPIDIC WESTERN DIETSJOURNAL OF HEPATOLOGY
Artículo2015Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort studyJOURNAL OF HEPATOLOGY
Resumen congreso2015PHARMACOGENOMIC STUDY TO PREDICT RIBAVIRIN AND PROTEASE-INHIBITOR-RELATED ANEMIA IN HEPATITIS CJOURNAL OF HEPATOLOGY
Resumen congreso2015QUERCETIN MODIFIES LIPID DROPLET MORPHOLOGY AND IMPAIRS HEPATITIS C VIRAL LIFE-CYCLE STEPS FROM ASSEMBLY TO REPLICATION STEPSJOURNAL OF HEPATOLOGY
Resumen congreso2015ROLE OF EPIGENETIC FACTORS IN NON-ALCOHOLIC STEATOHEPATITIS DEVELOPMENTJOURNAL OF HEPATOLOGY
Resumen congreso2015TYPE 2 DIABETES REDUCES OVERALL SURVIVAL AND INCREASES THE RISK OF HEPATIC DECOMPENSATION IN HCV-RELATED LIVER CIRRHOSIS. RESULTS FROM A PROSPECTIVE LONG-TERM STUDY DURING 8 YEARSJOURNAL OF HEPATOLOGY
Resumen congreso2015WEIGHT LOSS INTENSITY IS STRONGLY ASSOCIATED TO IMPROVEMENT OF HISTOLOGICAL PARAMETERS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AFTER 52 WEEKS OF LIFESTYLE MODIFICATIONJOURNAL OF HEPATOLOGY
Resumen congreso2014ANABOLIC ANDROGENIC STEROIDS (AAS) ILLICIT USE IS A RAPIDLY GROWING CAUSE OF DRUG-INDUCED LIVER INJURY (DILI): A PROSPECTIVE SERIES FROM THE SPANISH-LATIN-AMERICAN DILI REGISTRYJOURNAL OF HEPATOLOGY
Artículo2014Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activationJOURNAL OF HEPATOLOGY
Resumen congreso2014COMPARISONS OF POPULATIONS IN FALDAPREVIR PHASE III STUDIES BASED ON PEGYLATED INTERFERON alpha-2a AND RIBAVIRIN-PREDICTED RESPONSIVENESS AND IMPACT ON ACHIEVING SVR12JOURNAL OF HEPATOLOGY
Resumen congreso2014DETECTION AND DERIVATION RATE AFTER PEER-TO-PEER TRAINING SESSIONS IN PRIMARY CARE ON THE SCREENING OF HEPATITIS BJOURNAL OF HEPATOLOGY
Resumen congreso2014EARLY STOPPING RULES FOR FALDAPREVIR PLUS PEGYLATED INTERFERON alpha-2a AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS: EXPLORATORY STUDY OF POOLED DATA FROM PHASE III TRIALSJOURNAL OF HEPATOLOGY
Resumen congreso2014EFFICACY AND SAFETY OF BOCEPREVIR-BASED THERAPY IN HCVG1 TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED FIBROSIS/CIRRHOSIS: THE ITALIAN AND SPANISH NPP EARLY ACCESS PROGRAMJOURNAL OF HEPATOLOGY
Resumen congreso2014FALDAPREVIR PLUS PEGYLATED INTERFERON/RIBAVIRIN DID NOT INCREASE ANAEMIA COMPARED WITH PEGYLATED INTERFERON/RIBAVIRIN IN HCV GENOTYPE-1, TREATMENT-NAIVE PATIENTS: POOLED ANALYSIS OF PHASE III STUDIESJOURNAL OF HEPATOLOGY
Resumen congreso2014FINE MAPPING OF THE BUTYROPHILIN GENOMICS REGION: ROLE IN HEPATITIS C VIRUS INFECTION (HCV)JOURNAL OF HEPATOLOGY
Resumen congreso2014GLUTAMINASE GENE ALTERATION DETERMINES THE ABILITY TO PREDICT OVERT HEPATIC ENCEPHALOPATHY BOUTS BY CRITICAL FLICKER FREQUENCY AND ORAL GLUTAMINE CHALLENGEJOURNAL OF HEPATOLOGY
Artículo2014IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infectionJOURNAL OF HEPATOLOGY
Resumen congreso2014LOSS OF GATA4 IN HEPATIC STELLATE CELLS PROMOTES LIVER FIBROSISJOURNAL OF HEPATOLOGY
Resumen congreso2014META-ANALYSIS: ROLE OF INSULIN SENSITIZERS ADDED TO PEGINTERFERON AND RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS CJOURNAL OF HEPATOLOGY
Resumen congreso2014NON-INVASIVE MANAGEMENT OF NON-ALCOHOLIC FATTY LIVER DISEASEJOURNAL OF HEPATOLOGY
Artículo2014Ornithine phenylacetate targets alterations in the expression and activity of glutamine synthase and glutaminase to reduce ammonia levels in bile duct ligated ratsJOURNAL OF HEPATOLOGY
Resumen congreso2014PROGNOSTIC MODEL FOR PREDICTING DRUG-INDUCED ACUTE LIVER FAILUREJOURNAL OF HEPATOLOGY
Resumen congreso2014QUERCETIN MODULATES LIPIDS DROPLETS IN Huh7 CELLS BEARING PNPLA3 GENOTYPE GGJOURNAL OF HEPATOLOGY
Resumen congreso2014Regulation of the akt/mtor pathway by metformin in hepatocellular carcinoma development upon hcv infectionJOURNAL OF HEPATOLOGY
Letter2014Reply to: "Renal impairment and anemia during triple therapy"JOURNAL OF HEPATOLOGY
Resumen congreso2014TELAPREVIR-BASED TRIPLE THERAPY IN PATIENTS WITH MODERATE FIBROSIS. SPANISH MULTICENTRE STUDY IN CLINICAL PRACTICEJOURNAL OF HEPATOLOGY
Artículo2014Use of artificial intelligence as an innovative donor-recipient matching model for liver transplantation: Results from a multicenter Spanish studyJOURNAL OF HEPATOLOGY
Resumen congreso2013A candidate-gene approach to validation of genetic modifier associations using a large cohort with histologically characterised non-alcoholic fatty liver diseaseJOURNAL OF HEPATOLOGY
Resumen congreso2013AN ALLELIC VARIANT IN THE IRF3 GENE IS ASSOCIATED WITH LIVER CIRRHOSIS IN HEPATITIS C VIRUS CARRIERSJOURNAL OF HEPATOLOGY
Revisión2013Clinical management of drug-drug interactions in HCV therapy: Challenges and solutionsJOURNAL OF HEPATOLOGY
Ponencia2013Determination of fibrosis stage and steatohepatitis in patients with nafld by optical analysis of magnetic resonance images combined with artificial neural networks (Fibromri and nashmri)JOURNAL OF HEPATOLOGY
Resumen congreso2013Early virological response rates in monoinfected patients with HCV and coinfected with HCV/HIV, genotypes 1&4 treated with peginterferon alpha 2a and ribavirin. Optim studyJOURNAL OF HEPATOLOGY
Resumen congreso2013Efficacy and safety of triple-therapy with peginterferon-ribavirin, and boceprevir as compassionate-use in Spanish patients with hepatitis C genotype 1 with severe fibrosis: Interim-analysis at 12 weeksJOURNAL OF HEPATOLOGY
Resumen congreso2013Functional analysis of the diacylglycerol acyltransferase activity-1 (DGAT1) in the replication of hepatitis C virus: Effect of quercetinJOURNAL OF HEPATOLOGY
Resumen congreso2013GENETIC VARIATIONS IN proprotein convertase subtilisin/kexin type 9 (PCSK9) GENE ARE ASSOCIATED WITH RESPONSE TO PEGYLATED INTERFERON/RIBAVIRIN IN HEPATITIS C VIRUS GENOTYPE 3-INFECTED PATIENTSJOURNAL OF HEPATOLOGY
Resumen congreso2013Histological severity independently predicts early atherosclerotic lesions and 10 year cardiovascular risk in NAFLD patientsJOURNAL OF HEPATOLOGY
Resumen congreso2013I148M PNPLA3 variant promotes steatosis according to viral and IL28B genotype but does not affect sustained viral response in patients with hepatitis CJOURNAL OF HEPATOLOGY
Resumen congreso2013IL28B-based model for prediction of week 4 viral response in peginterferon-alfa2a+ribavirin treated hepatitis C genotype 1&4. Final report week 4 optim studyJOURNAL OF HEPATOLOGY
Resumen congreso2013KLF12 polymorphism rs9543524 predicts anemia in patients with chronic hepatitis C treated with peginterferon and ribavirinJOURNAL OF HEPATOLOGY
Revisión2013Management of anemia induced by triple therapy in patients with chronic hepatitis C: Challenges, opportunities and recommendationsJOURNAL OF HEPATOLOGY
Resumen congreso2013Non-alcoholic steatohepatitis increases the production of antibodies against oxidized LDL, atherosclerosis and cardiovascular riskJOURNAL OF HEPATOLOGY
Resumen congreso2013Phase II HCVac study of TG4040 immunotherapeutic in combination with PEGIFN alpha 2a and ribavirin in genotype 1 CHC treatment naive patients: SVR24 final resultsJOURNAL OF HEPATOLOGY
Resumen congreso2013Role of gene and microRNAs expression related to hepatocellular carcinoma development in a hcv-induced model in vitro. Effect of metforminJOURNAL OF HEPATOLOGY
Resumen congreso2013Role of protein tyrosine-phosphatase 1B (PTP1B) activity in HCV-induced hepatocellular carcinoma: An in vitro analysisJOURNAL OF HEPATOLOGY
Resumen congreso2013The HOMA index is a useful tool for risk stratification of advanced fibrotic disease in a large cohort of european NAFLD patientsJOURNAL OF HEPATOLOGY
Ponencia2012A GENOME-WIDE ASSOCIATION STUDY IDENTIFIED A NOVEL SUSCEPTIBILITY LOCUS GENE PBK (RS 17388536)FOR SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS BEARING IL28B GENOTYPE CCJOURNAL OF HEPATOLOGY
Ponencia2012EFFECT OF ABCC2 HAPLOTYPES ON INDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (DILI) SUSCEPTIBILITYJOURNAL OF HEPATOLOGY
Ponencia2012FACTORS INVOLVED IN SUSTAINED VIRAL RESPONSE (SVR) ACHIEVEMENT IN PATIENTS WITH FAVORABLE IL28B CC GENOTYPE IN HEPATITIS CJOURNAL OF HEPATOLOGY
Ponencia2012HEPATITIS C VIRUS MODIFIES PROTEIN AND GENE EXPRESSION OF THE INSULIN SIGNALING PATHWAY IN VIVO AND IN VITROJOURNAL OF HEPATOLOGY
Ponencia2012HEPATITIS C VIRUS MODIFIES THE EXPRESSION OF MICRO-RNAS ASSOCIATED WITH APOPTOSIS AND METABOLIC SYNDROME IN HUH7.5 CELLSJOURNAL OF HEPATOLOGY
Ponencia2012HEPATITIS C VIRUS MODULATES LDL RECEPTOR (LDLR) GENE EXPRESSION IN PERIPHERAL BLOOD MONONUCLEAR CELLS ACCORDING TO VIRAL CLEARANCEJOURNAL OF HEPATOLOGY
Ponencia2012HIGH VS STANDARD DOSE OF RIBAVIRIN PLUS PEGINTERFERON-ALFA-2A IN CHRONIC HEPATITIS C, GENOTYPE 3 AND HIGH VIRAL LOAD. FINAL RESULTS OF THE DARGEN-3 STUDYJOURNAL OF HEPATOLOGY
Ponencia2012INTERACTION BETWEEN RS12979860 POLYMORHISM OF IL28B GENE WITH BASELINE PREDICTIVE FACTORS OF RESPONSE TO TREATMENT IN PATIENTS WITH HEPATITIS CJOURNAL OF HEPATOLOGY
Ponencia2012METFORMIN PREVENTS OVERT HEPATIC ENCEPHALOPATHY (HE) IN CIRRHOTICS: A RETROSPECTIVE OBSERVATIONAL STUDYJOURNAL OF HEPATOLOGY
Ponencia2012METFORMIN TREATMENT REDUCES HEPATOCELLULAR CARCINOMA (HCC) RISK IN PATIENTS WITH CIRRHOSIS C: A RETROSPECTIVE OBSERVATIONAL STUDY OF TWO INDEPENDENT COHORTSJOURNAL OF HEPATOLOGY
Ponencia2012Optical analysis of liver magnetic resonance images based on neural networks for the determination of fibrosis stage and distribution in non-alcoholic fatty liver disease (NAFLD)JOURNAL OF HEPATOLOGY
Ponencia2012PEGINTERFERON ALPHA-2A ACHIEVES HIGHER EARLY VIROLOGICAL RESPONSES (RVR AND CEVR) THAN PEGINTERFERON ALPHA-2B IN CHRONIC HEPATITIS C: META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS (RCT)JOURNAL OF HEPATOLOGY
Artículo2012Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA loadJOURNAL OF HEPATOLOGY
Editorial2011APOC3 polymorphisms and non-alcoholic fatty liver disease: Resolving some doubts and raising othersJOURNAL OF HEPATOLOGY
Ponencia2011EFFECTS OF CHEMICAL MOIETIES AND POLYMORPHISMS IN THE HUMAN ABC TRANSPORTER ABCB1 (P-GLYCOPROTEIN/MDR1) IN DRUG-INDUCED LIVER INJURYJOURNAL OF HEPATOLOGY
Ponencia2011HEPATITIS C VIRUS INFECTION ALTERS LIPID METABOLISM DEPENDING ON THE RS12979860 POLYMORPHISM IN THE IL28B GENEJOURNAL OF HEPATOLOGY
Ponencia2011IBUPROFEN-ASSOCIATED HEPATOTOXICITY: ANALYSIS OF A CASE SERIES INCLUDED IN THE SPANISH DILI REGISTRYJOURNAL OF HEPATOLOGY
Ponencia2011NITRIC OXIDE MIMICKS TRANSCRIPTIONAL AND POST-TRANSLATIONAL REGULATION DURING alpha-TOCOPHEROL CYTOPROTECTION AGAINST GLYCOCHENODEOXYCHOLATE-INDUCED CELL DEATH IN HEPATOCYTESJOURNAL OF HEPATOLOGY
Artículo2011Nitric oxide mimics transcriptional and post-translational regulation during α-Tocopherol cytoprotection against glycochenodeoxycholate-induced cell death in hepatocytesJOURNAL OF HEPATOLOGY
Ponencia2011ONCE DAILY ALISPORIVIR (DEB025) PLUS PEGIFNALFA2A/RIBAVIRIN RESULTS IN SUPERIOR SUSTAINED VIROLOGIC RESPONSE (SVR24) IN CHRONIC HEPATITIS C GENOTYPE 1 TREATMENT NAIVE PATIENTSJOURNAL OF HEPATOLOGY
Ponencia2011ROLE OF RAPAMYCIN AS MTOR INHIBITOR IN VITRO AND ITS USE IN THE TREATMENT OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATIONJOURNAL OF HEPATOLOGY
Ponencia2011THDP-17 inhibits selectively the k-type intestinal glutaminase, but not the type-l in vitro and in vivoJOURNAL OF HEPATOLOGY
Ponencia2010Differential protein expression in the cerebellum of portocaval-shunted rats: a dige/ms studyJOURNAL OF HEPATOLOGY
Ponencia2010DOUBLE-BLINDED CROSSOVER TRIAL ANALYZING THE USEFULNESS OF RIFAXIMIN IN THE TREATMENT OF MINIMAL HEPATIC ENCEPHALOPATHY (MHE): AN INTERIN ANALYSISJOURNAL OF HEPATOLOGY
Ponencia2010Genome-wide association and high throughput genotype imputation studies confirm a susceptibility locus to hcv infection on 6p22.1-p21.31JOURNAL OF HEPATOLOGY
Ponencia2010IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (DILI): FOLLOW-UP IN A COHORT OF PATIENTS IDENTIFIED IN 24 TERTIARY CARE CENTRES IN SPAINJOURNAL OF HEPATOLOGY
Ponencia2010IGF-1 replacement therapy in rats with hepatic encephalopathy induced by portacaval shuntJOURNAL OF HEPATOLOGY
Ponencia2010IL28B GENETIC VARIANTS AND HEPATITIS VIRUS INFECTION BY DIFFERENT VIRAL GENOTYPESJOURNAL OF HEPATOLOGY
Ponencia2010THDP-17 inhibits the glutaminase activity in caco-2 cell culturesJOURNAL OF HEPATOLOGY
Ponencia2010The HLA class i b*1801 allele influences hepatocellular expression of amoxicillin-clavulanate liver damage and outcome in spanish patientsJOURNAL OF HEPATOLOGY
Corrección2009Analysis of IL-10, IL-4 and TNF-alpha Polymorphisms in Drug-induced liver injury (DILI) and its outcome (vol 49, pg 107, 2008)JOURNAL OF HEPATOLOGY
Ponencia2009GENOTYPE DISTRIBUTION OF THE HEPATIC CANALICULAR TRANSPORTER ABCC2-24C > T POLYMORPHISM IS NOT RELATED TO DRUG-INDUCED IDIOSYNCRATIC LIVER INJURY (DILI). RELEVANCE OF ETHNIC VARIANTS IN EUROPEANSJOURNAL OF HEPATOLOGY
Ponencia2009IMPORTANCE OF HLA-DQB1(star)0301 AS PREDICTIVE FACTOR OF SUSTAINED VIROLOGIC RESPONSE (SVR) IN PATIENTS WITH CHRONIC HEPATITISC (CHC), GENOTYPE-1, TREATED WITH PEGINTERFERON (PEGIFN) AND RIBAVIRIN (RBV)JOURNAL OF HEPATOLOGY
Artículo2009Insulin resistance is not a relevant predictor of sustained virological response to pegylated interferon plus ribavirin in HIV/HCV co-infected patientsJOURNAL OF HEPATOLOGY
Ponencia2009POSITIONAL CLONING IN GLS GENE: A MICROSATELLITE IN THE PROMOTER REGION PREDICTS THE RISK OF HEPATIC ENCEPHALOPATHYJOURNAL OF HEPATOLOGY
Artículo2008Analysis of IL-10, IL-4 and TNF-alpha polymorphisms in drug-induced liver injury (DILI) and its outcomeJOURNAL OF HEPATOLOGY
Artículo2008Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patientsJOURNAL OF HEPATOLOGY
Ponencia2008Combined glutathione-s-transferase M1 and T1 genetic polymorphism and susceptibility to develop drug-induced idiosyncratic liver injury (DILI)JOURNAL OF HEPATOLOGY
Artículo2008Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis CJOURNAL OF HEPATOLOGY
Ponencia2008Insulin resistance predicts risk for the development of variceal bleedingJOURNAL OF HEPATOLOGY
Ponencia2008Interim analysis from TRIC-1 a study of metformin with peginterferon alfa-2a and ribavirin in treatment naive genotype 1 chronic hepatitis C with insulin resistanceJOURNAL OF HEPATOLOGY
Resumen congreso2008Peginterferon plus ribavirin and sustained virological response on HCV cirrhosis: Effect on liver-related event free survival and factors predicting response: A retrospective multicenter analysisJOURNAL OF HEPATOLOGY
Ponencia2008Smoking and hepatitis C: Influence on fibrosis progression and sustained responseJOURNAL OF HEPATOLOGY
Ponencia2008The expression of p27 reduces DNA mutagenesis and cell death in aflatoxin B1 induced genotoxicity in hepatocytes. Impact of p27 and p21 in human hepatocarcinogenesisJOURNAL OF HEPATOLOGY
Ponencia2008The influence of age and gender in the biochemical expression of idiosyncratic liver injuryJOURNAL OF HEPATOLOGY
Ponencia2007Assessment of fibrosis distribution in patients with chronic hepatitis C using computerperformed optical analysis of CT of the liver (FibroCT (R))JOURNAL OF HEPATOLOGY
Editorial2007Critical flicker frequency: It is time to break down barriers surrounding minimal hepatic encephalopathyJOURNAL OF HEPATOLOGY
Ponencia2007Haplotypes TACG and CACG from glutaminase gene protect against hepatic encephalopathyJOURNAL OF HEPATOLOGY
Ponencia2007How can we identify HCV genotype 1 patients who may benefit from an extended treatment duration with peginterferon alpha-2a (40kD) plus RBV?JOURNAL OF HEPATOLOGY
Ponencia2007Influence of insulin resistance and ribavirin dosage in viral dynamics of patients with chronic hepatitis C genotype 1 treated with peginterferon and ribavirinJOURNAL OF HEPATOLOGY
Artículo2006Acute hepatitis due to Mycoplasma pneumoniae infection without lung involvement in adult patientsJOURNAL OF HEPATOLOGY
Ponencia2006Amoxicillin-clavulanate (AC) associated hepatotoxicity: Analysis of a single country large cohort prospectively identifiedJOURNAL OF HEPATOLOGY
Ponencia2006Chronic liver damage after an episode of idiosyncratic drug induced liver injury (DILI)JOURNAL OF HEPATOLOGY
Ponencia2006Insulin resistance in co-infected HCV/HIV patients: A negative factor influencing sustained response to peginterferon plus ribavirinJOURNAL OF HEPATOLOGY
Ponencia2006Peginterferon alpha-2a (40KD) (PEGASYS (R)) plus ribavirin (COPEGUS (R)) for treating chronic hepatitis C genotype 1 in daily clinical practice: Final results of the Heracles projectJOURNAL OF HEPATOLOGY
Ponencia2006Pharmacokinetics and pharmacodynamics of induction doses of peginterferon alpha-2a (40KD) (PEGASYS (R)) and ribavirin (COPEGUS (R)) in HCV genotype 1 patients who failed to respond to interferon/ribavirinJOURNAL OF HEPATOLOGY
Ponencia2006Protein oxidation in astrocyte of porto-caval shunted rats: Role of oxidative stress in hepatic encephalopathyJOURNAL OF HEPATOLOGY
Ponencia2006Sustained response in chronic hepatitis C reduces the risk to develop impaired fasting glucose and/or diabetes mellitus type 2JOURNAL OF HEPATOLOGY
Ponencia2006Usefulness of the measurement of critical flicker frequency in the diagnosis of minimal hepatic encephalopathy (MHE)JOURNAL OF HEPATOLOGY
Ponencia2005Bcl-2 expression in ductular proloferation induces fibrosis progression promoting activation of hepatic stellate cells in autoimmune cholestasisJOURNAL OF HEPATOLOGY
Ponencia2005Development and validation of a simple model to predict response to peginterferon plus ribavirin combination therapy in genotype 1 chronic hepatitis CJOURNAL OF HEPATOLOGY
Ponencia2005Fibrosis assessment in hepatitis C by computerper-formed optical analysis of CT of the liver: A novel nowinvasive and useful methodJOURNAL OF HEPATOLOGY
Ponencia2005Glutaminase activity is implicated in the pathogenesis of hyperammonemia in portocaval shunted ratsJOURNAL OF HEPATOLOGY
Ponencia2005Hepatic encephalopathy is more frequent, severe and shortens the survival in HCV/HIV-related cirrhosisJOURNAL OF HEPATOLOGY
Ponencia2005Insulin resistance promotes fibrosis progression and predicts necro-inflammatory activity in patients with non-alcoholic fatty liver diseaseJOURNAL OF HEPATOLOGY
Ponencia2005Oral glutamine challenge response is regulated by portal hypertension and systemic inflammatory responseJOURNAL OF HEPATOLOGY
Ponencia2005Preliminary health outcome results of peginterferon alpha-2a (40kDa) plus ribavirin treatment for chronic hepatitis C genotype 1 in daily routine clinical practice: The heracles projectJOURNAL OF HEPATOLOGY
Letter2004Hepatotoxicity induced by clopidogrelJOURNAL OF HEPATOLOGY
Ponencia2004Insulin resistance, fibrosis and genotype are predictors of sustained response rate to pegylated interferon plus ribavirin in patients with chronic hepatitis CJOURNAL OF HEPATOLOGY
Artículo2004Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathyJOURNAL OF HEPATOLOGY
Ponencia2004Sustained virological response after prolonged treatment with peginterferon alfa-2a (40kd) (PEGASYS (R)) and ribavirin (COPEGUS (R)) in treatment-naive patients with chronic hepatitis C and detectable HCV RNA after week 4 of therapy: Teravic-4 studyJOURNAL OF HEPATOLOGY
Ponencia2003Interferon alpha-2a in combination therapies for the treatment of chronic hepatitis C in prior non-responders to interferon monotherapyJOURNAL OF HEPATOLOGY
Ponencia2003Role of the inhibition of NF-kappa B activation during PGE1 protection against D-galactosamine-induced apoptosis in primary culture of rat hepatocytesJOURNAL OF HEPATOLOGY
Ponencia2003Thymic function is impaired in adult hepatitis C virus co-infected patients on HAARTJOURNAL OF HEPATOLOGY
Letter2002Acute liver failure caused by diffuse hepatic melanoma infiltrationJOURNAL OF HEPATOLOGY
Artículo2002Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathyJOURNAL OF HEPATOLOGY
Ponencia2002Hepatitis C and diabetes mellitus: What is the connection?JOURNAL OF HEPATOLOGY
Ponencia2002NF-kB activation is involved on PGE1 protection against D-galactosamine-induced apoptosis in primary culture of rat hepatocytesJOURNAL OF HEPATOLOGY
Ponencia2002Oral glutamine challenge correlates with minimal hepatic encephalopathy and predicts overt episodesJOURNAL OF HEPATOLOGY
Ponencia2002Role of leptin and hepatic stellate cell (HSC) in the development of steatosis in chronic hepatitis CJOURNAL OF HEPATOLOGY
Ponencia2002Spur cell anaemia in hepatic cirrhosis: Incidence, prognosis and reversibility after liver transplantationJOURNAL OF HEPATOLOGY
Letter2001Hepatotoxicity induced by fosinoprilJOURNAL OF HEPATOLOGY
Resumen congreso2001Host and viral factors in hepatocyte steatosis detected in chronic hepatitis CJOURNAL OF HEPATOLOGY
Ponencia2001Oral glutamine challenge in patients with subclinical hepatic encephalopathyJOURNAL OF HEPATOLOGY
Letter2001Orlistat associated subacute hepatic failureJOURNAL OF HEPATOLOGY
Artículo2001Pancreastatin, a chromogranin A-derived peptide, inhibits DNA and protein synthesis by producing nitric oxide in HTC rat hepatoma cellsJOURNAL OF HEPATOLOGY
Resumen congreso2001Pathogenesis of hyperintensity in the globus palidus (HIGP) in cirrhotic patientsJOURNAL OF HEPATOLOGY
Resumen congreso2001Transient rebound of HCV RNA levels among HIV/HCV-coinfected patients early after starting highly active antiretroviral therapy (HAART)JOURNAL OF HEPATOLOGY
Ponencia2000HLA antigens in chronic hepatitis C: Relationship with interferon response and severity of liver injuryJOURNAL OF HEPATOLOGY
Ponencia2000Manganese level in patients with subclinical hepatic encephalopathy (SHE)JOURNAL OF HEPATOLOGY
Ponencia2000PGE(1) reduced caspase-3 and-6 activation induced by D-galactosamine in primary culture of rat hepatocytes, role of oxidative stressJOURNAL OF HEPATOLOGY
Ponencia2000PREVALENCE AND CLINICAL SIGNIFICANCE OF ANTIPHOSPHOLIPID ANTIBODIES (APA) IN VIRAL CHRONIC LIVER DISEASEJOURNAL OF HEPATOLOGY
Ponencia2000Risk factors of fungal infection in liver transplantation for acute liver failureJOURNAL OF HEPATOLOGY
Artículo1999Acute liver injury associated with the use of ebrotidine, a new H2- receptor antagonistJOURNAL OF HEPATOLOGY
Artículo1999Hepatitis C virus infection in childrenJOURNAL OF HEPATOLOGY
Letter1999Rapid progression to liver cirrhosis of toxic hepatitis due to ebrotidineJOURNAL OF HEPATOLOGY
Artículo1997Unexpected high prevalence of hepatitis C virus genotype 4 in southern SpainJOURNAL OF HEPATOLOGY
Artículo1994PREDICTION OF SUSTAINED REMISSION OF CHRONIC HEPATITIS-C AFTER A 12-MONTH COURSE OF ALFA INTERFERONJOURNAL OF HEPATOLOGY
Artículo1993HEPATITIS-B VIRUS OCCULT INFECTION IN SUBJECTS WITH PERSISTENT ISOLATED ANTI-HBC REACTIVITYJOURNAL OF HEPATOLOGY
Resumen congreso1988Clinical-evidence of the existence of 2 non-a, non-b agents with dissimilar clinical behavior and prognosisJOURNAL OF HEPATOLOGY
Artículo1986ROTATIVE AGITATION RIA - A HIGH-SENSITIVITY TECHNIQUE FOR HEPATITIS-B SURFACE-ANTIGEN (HBSAG) DETERMINATIONSJOURNAL OF HEPATOLOGY